ARO-DM1

· Arrowhead Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARO-DM1, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy [Phase 1, Phase 2]